Google
Trusted Resources: News & Events
Latest announcements and gatherings
World’s Largest Sickle Cell Disease Stem Cell Library Underway
Scientists in Boston are creating a stem cell library that could write a new chapter for far-reaching possibilities in sickle cell disease (SCD) research and innovative therapy development.
The library comprises sickle cell disease-specific induced pluripotent stem cells (iPSCs), which can can renew as many times as necessary without any type of differentiation, meaning they can be directed to grow as any tissue or organ. This characteristic makes iPSCs particularly helpful to create disease models in labs, helping scientists understand how diseases develop.
+myBinderRelated Content
-
Social Media Discussions Provide new Insight About Perceptions of Hydroxyurea in the Sickle Cell CommunityHydroxyurea (HU) has proven efficacious ...
-
Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell DisordersAnnual evaluation by Trans-Cranial Doppl...
-
Global Blood Therapeutics (GBT) announces upcoming data presentations supporting Voxelotor SCD programGlobal Blood Therapeutics, Inc. (GBT) ...
-
Calimmune Expands Lentiviral Gene Therapy Pipeline Through License of Sickle Cell Disease Therapeutic CandidateLicense of Gamma-Globin from Cincinnati ...
-
FDA Advisory Committee Recommends Approval of Endari™ from Emmaus Life Sciences for the Treatment of Sickle Cell D...Emmaus Life Sciences Inc. announced toda...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Family Celebrates 7-Year-Old’s Sickle Cell Cure Thanks to Sister’s Life-Saving GiftOne 7-year-old who suffered his whole li...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.